From: HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers
Sex/Group | Patient ident | Sample Id/Time of sample collection after onset or study initiation | Age at time of sample collection | Patient age at time of biopsy collection | Knodell Index | K130M/V131I | HBeAg/Anti-HBe | TSGO/TSGP |
---|---|---|---|---|---|---|---|---|
M/B | 950-08 | 865M/2 y | 4 | -/- | +/- | 50/32 | ||
6217M/12 y | 14 | 15 | 2+1 = 3 | +/+ | -/- | |||
M/B | 671-10 | 445E/19 d | 8 | -/- | +/- | 74/83 | ||
5252M/9Y | 17 | 18 | 2+2 = 4 | +/+ | -/+ | 32/18 | ||
M/C | 266-03 | 3751M/8 m | 35 | -/- | -/+ | 32/13 | ||
6400M/6 y | 40 | 40 | 3+3 = 6 | +/+ | -/- | 36/13 | ||
M/B | 496-04 | 6461E/2 y | 12 | -/+ | -/- | 45/40 | ||
4904M/7 y | 17 | 19 | 2+1 = 3 | +/+ | -/+ | 28/25 | ||
M/B | 969-04 | 467H/23 d | 24 | deletion | -/- | 500/550 | ||
6604M/7 y | 31 | 32 | HCC 5+2 = 7 | +/+ | -/- | ND/18 | ||
M/C | 1232-06 | 1481M/10 m | 12 | -/+ | -/+ | 36/21 | ||
6290M/9 y | 22 | 23 | 2+1= 3 | -/- | -/+ | |||
M/C | 65-35 | 6891M/11 y | +/+ | -/+ | 55/50 | |||
20 | 20 | 3+0 = 3 | ||||||
M/C | 158-01 | 6151M/11 y | +/+ | -/+ | 36/16 | |||
33 | 35 | 1+2 = 3 | ||||||
M/C | 921-07 | 6403M/10 y | +/+ | -/- | 28/21 | |||
31 | 32 | 3+1 = 4 | ||||||
M/C | 673-04 | 6572M/8 y | -/- | -/- | ND/9 | |||
25 | 26 | 3+1 = 4 | ||||||
M/C | 5-02 | 6067M/9 y | 2+2 = 4 | -/- | -/+ | 32/16 | ||
53 | 54 | |||||||
M/C | 671-06 | 6593M/15 y | -/- | -/- | ND/13 | |||
26 | 26 | 4+3 = 7 | ||||||
M/C | 671-09 | 5251M/9y | 2+4 = 6 | -/- | -/+ | 28/18 | ||
16 | 19 | |||||||
M/B | 1688-16 | 3254H/3 d | 3 | HCC | -/- | -/- | 475/225 | |
16 | 6653M/3 y | 6 | NB | +/+ | -/- | ND/36 | ||
M/B | 1400-01 | 575H/2 d | 65 | HCC | -/- | -/- | 610/1200 | |
5433M/4 Y | 69 | T | -/- | +/- | 55/55 | |||
6825H/7 y | 72 | -/- | +/- | ND/55 | ||||
M/C | 1205-15 | 5399M/7 y | 35 | HCC | -/- | -/+ | 32/28 |